Pfizer is the world’s largest research-based biomedical and pharmaceutical company. Our corporate headquarters are located in New York, with major research and development locations in the United States and England. Recent innovations include Sutent®—a novel cancer medicine that both cuts off the blood supply that feeds tumors and destroys cellular reproduction, and Chantix®—a new prescription medicine and accompanying support plan designed specifically to help smokers quit. In 2007, Pfizer earned $48.4 billion in revenues and invested $8.1 billion in research and development.
|Five Prime Therapeutics||5/2008||Venture Round||1|
|Avid Radiopharmaceuticals||5/2007||Series C||$26M||6|
|Genizon BioSciences||2/2007||Series D||C$10M||2|
|Avid Radiopharmaceuticals||1/2006||Series A||$8.9M||4|
|Coley Pharmaceutical Group||3/2005||Venture Round||$10M||1|